About ClinicalMind
Editorial Mission
ClinicalMind is a research and industry publication covering the application of artificial intelligence in healthcare. Our mission is to provide healthcare professionals, researchers, policy professionals, and health system administrators with rigorous, evidence-grounded, source-attributed coverage of clinical AI applications, primary research literature, regulatory developments, company profiles, and market intelligence.
ClinicalMind is not a vendor marketing channel, a clinical guidance resource, or speculative health journalism. Every content group on the site has an explicit editorial standard: sources are cited, evidence quality is labeled, known limitations are surfaced, and content that cannot be independently verified is not published.
The site is designed to serve a multi-persona professional audience — clinicians verifying a clinical AI claim, researchers tracing primary literature, policy professionals monitoring regulatory developments, procurement teams evaluating AI vendors, and learners building AI literacy in their clinical domain.
Editorial Standards and Source Requirements
Source Standards
- Research summaries are drawn from peer-reviewed journals — NEJM AI, JAMA, Nature Medicine, npj Digital Medicine, Lancet Digital Health — and are linked to original publications via DOI or PMID. Summaries do not reproduce copyrighted text.
- Regulatory and policy content is sourced from primary regulatory documents — FDA, CMS, WHO, CHAI, EMA — and links directly to the official source. Speculative policy commentary without cited basis is excluded.
- Company and product profiles are sourced from independently verifiable information. Vendor-supplied performance claims presented without independent corroboration are excluded. All profiles carry a last-verified date.
- Clinical application analyses include evidence quality labels (RCT, prospective multi-center study, retrospective study, expert consensus), known limitations, and regulatory status. Vendor marketing narratives are excluded.
- Industry intelligence market figures are cited with source organization and include methodology caveats. Vendor-sourced data is distinguished from independent research firm data.
- Glossary entries cite authoritative definitional sources (FDA glossary, CHAI standards, NIH, primary literature). Marketing definitions are excluded.
Evidence Quality Labeling
ClinicalMind applies structured evidence quality labels across clinical application analyses and research summaries. These labels — RCT, prospective multi-center study, retrospective single-center study, expert consensus — communicate the strength of supporting evidence directly at the list and detail page level, enabling readers to assess clinical validity without reading the full entry.
Known limitations are surfaced as structured fields visible in list summaries and detail pages — not buried in body text — to reinforce the site’s evidence-critical editorial standard.
Conflict of Interest and Editorial Independence
ClinicalMind editorial content is independent of commercial relationships with companies profiled or referenced on the site. Profiles, clinical application analyses, and research summaries are produced without payment from profiled companies.
Where any commercial or funding relationship affects content, it will be disclosed explicitly within the relevant content entry. Sponsored content, if any, is clearly labeled as such and is editorially separated from independent editorial content.
ClinicalMind requires that all cited research disclose funding sources and author conflict-of-interest statements. These disclosures are reproduced in research summary entries to support readers evaluating the independence of findings.
Correction and Update Policy
Factual errors are corrected promptly. Corrections are noted within the relevant content entry. Significant corrections are disclosed at the top of the affected entry.
Company and product profiles carry a last-verified date indicating when profile information was most recently reviewed. The healthcare AI landscape changes rapidly; readers should verify current regulatory status and product details directly with the issuing authority or company.
Policy Tracker entries link to the primary regulatory document. When a regulatory action is superseded or corrected, the tracker entry is updated and the update date is displayed.
To submit a factual correction, contact us via the contact page. Please include the URL of the affected entry, the specific error, and the correct information with a source citation.
Medical Responsibility
ClinicalMind content is for informational purposes for healthcare professionals and researchers. It does not constitute clinical guidance, medical diagnosis, treatment advice, or medication recommendations. It does not replace professional medical judgment or the advice of a qualified healthcare professional.
Readers must consult qualified healthcare professionals for clinical decisions. AI tools described on this site should not be used for individual patient care without appropriate clinical oversight, regulatory authorization, and institutional validation.
For the full formal disclaimer, see the ClinicalMind Disclaimer.